Ari Maizel, Chief Commercial Officer at Axsome Therapeutics, Inc. (AXSM), sold 7,500 shares at $184.44 ($1.4M) on 2026-01-21, disclosed to the SEC on 2026-01-23.
Open-market sale of $1.4M AXSM by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.